Platelet-Rich Plasma Therapy with Excelents Results in the Treatment of Post-Infectious Telogen Effluvium

Abstract

Telogen Effluvium is defined as diffuse hair loss without scarring of the scalp which occurs after a stressful event. The storm of inflammatory cytokines can lead to the premature interruption of the anagen phase, resulting in excessive hair loss. The diagnosis is clinical. A 67-year-old woman with a previous diagnosis of stabilized androgenetic alopecia was infected with SARS-CoV-2 and, two months later, sought dermatological care due to intense hair loss. Telogen Effluvium was diagnosed in addition to her existing condition. Treatment involved the infiltration of active agents, combined with red LED and Fraxel laser in the affected area of the scalp, alternating with intralesional Platelet-Rich Plasma (PRP) injections into the scalp. Daily use of finasteride and oral biotin, along with topical minoxidil, was also part of the therapy. The result was significant hair recovery. Further research is needed to better define treatment guidelines.